Heterogeneity of Glucose Transport in Lung Cancer

Increased glucose uptake is a known hallmark of cancer. Cancer cells need glucose for energy production via glycolysis and the tricarboxylic acid cycle, and also to fuel the pentose phosphate pathway, the serine biosynthetic pathway, lipogenesis, and the hexosamine pathway. For this reason, glucose...

Full description

Bibliographic Details
Main Authors: Cesar A. Martinez, Claudio Scafoglio
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/6/868
id doaj-e02059c7aff54fe7bc88a07992c67051
record_format Article
spelling doaj-e02059c7aff54fe7bc88a07992c670512020-11-25T03:25:12ZengMDPI AGBiomolecules2218-273X2020-06-011086886810.3390/biom10060868Heterogeneity of Glucose Transport in Lung CancerCesar A. Martinez0Claudio Scafoglio1Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USADivision of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USAIncreased glucose uptake is a known hallmark of cancer. Cancer cells need glucose for energy production via glycolysis and the tricarboxylic acid cycle, and also to fuel the pentose phosphate pathway, the serine biosynthetic pathway, lipogenesis, and the hexosamine pathway. For this reason, glucose transport inhibition is an emerging new treatment for different malignancies, including lung cancer. However, studies both in animal models and in humans have shown high levels of heterogeneity in the utilization of glucose and other metabolites in cancer, unveiling a complexity that is difficult to target therapeutically. Here, we present an overview of different levels of heterogeneity in glucose uptake and utilization in lung cancer, with diagnostic and therapeutic implications.https://www.mdpi.com/2218-273X/10/6/868glucose metabolismglucose transportcancerlung cancertumor heterogeneity
collection DOAJ
language English
format Article
sources DOAJ
author Cesar A. Martinez
Claudio Scafoglio
spellingShingle Cesar A. Martinez
Claudio Scafoglio
Heterogeneity of Glucose Transport in Lung Cancer
Biomolecules
glucose metabolism
glucose transport
cancer
lung cancer
tumor heterogeneity
author_facet Cesar A. Martinez
Claudio Scafoglio
author_sort Cesar A. Martinez
title Heterogeneity of Glucose Transport in Lung Cancer
title_short Heterogeneity of Glucose Transport in Lung Cancer
title_full Heterogeneity of Glucose Transport in Lung Cancer
title_fullStr Heterogeneity of Glucose Transport in Lung Cancer
title_full_unstemmed Heterogeneity of Glucose Transport in Lung Cancer
title_sort heterogeneity of glucose transport in lung cancer
publisher MDPI AG
series Biomolecules
issn 2218-273X
publishDate 2020-06-01
description Increased glucose uptake is a known hallmark of cancer. Cancer cells need glucose for energy production via glycolysis and the tricarboxylic acid cycle, and also to fuel the pentose phosphate pathway, the serine biosynthetic pathway, lipogenesis, and the hexosamine pathway. For this reason, glucose transport inhibition is an emerging new treatment for different malignancies, including lung cancer. However, studies both in animal models and in humans have shown high levels of heterogeneity in the utilization of glucose and other metabolites in cancer, unveiling a complexity that is difficult to target therapeutically. Here, we present an overview of different levels of heterogeneity in glucose uptake and utilization in lung cancer, with diagnostic and therapeutic implications.
topic glucose metabolism
glucose transport
cancer
lung cancer
tumor heterogeneity
url https://www.mdpi.com/2218-273X/10/6/868
work_keys_str_mv AT cesaramartinez heterogeneityofglucosetransportinlungcancer
AT claudioscafoglio heterogeneityofglucosetransportinlungcancer
_version_ 1724598258825691136